Last reviewed · How we verify
Administration of ERC
At a glance
| Generic name | Administration of ERC |
|---|---|
| Sponsor | Medistem Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta (NA)
- Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone (PHASE2)
- Microteaching and Advanced Life Support Simulation: Effects on Student Satisfaction and Teamwork (NA)
- RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
- Non-Complex Biliary Stones DSC vs ERC (NA)
- Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest (NA)
- Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns (NA)
- Physiologically Based Cord Clamping To Improve Neonatal Outcomes After Elective Cesarean Delivery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Administration of ERC CI brief — competitive landscape report
- Administration of ERC updates RSS · CI watch RSS
- Medistem Inc. portfolio CI